First-line cadonilimab plus chemotherapy in HER2-negative advanced gastric or gastroesophageal junction adenocarcinoma: a randomized, double-blind, phase 3 trial
Published Online: 2025-01-22
Journal: Nature MedicineLoading...
Authors: Aimin Zang•Baiyong Li•Bangwei Cao•Bo Liu•Changzheng Li•Daqing Wang•Diansheng Zhong•Dongmei Lu•Drew M. Pardoll•Futong Zhang•Guohua Yu•Guowu Wu•Haiyan Liu•Hao Chen•Hao Liu•Hongming Pan•Hongyan Xu•Huiting Xu•Jia Wei•Jiafu Ji•Jiajia Zhang•Jian Chen•Jianying Jin•Jieer Ying•Jingdong Zhang•Jinghua Zhang•Jiye Xu•Jun Guo•Jun Zhao•Kangsheng Gu•Lian Liu•Lili Sheng•Lin Shen•Lin Xie•Lixin Wan•Lizhu Lin•Mafei Kang•Meiqing Wang•Michelle Xia•Ming Liu•Ming Xie•Minghui Zhang•Mingwei Huang•Mingxiu Hu•Mingzhu Huang•Mulin Liu•Ning Li•Nong Xu•Peng Nie•Qingshan Li•Ruixing Zhang•Shan Zeng•Shujuan Sun•Tao Zhang•Wei Li•Wei Liu•Weibo Wang•Wensheng Qiu•Wenxiang Dai•Wenxin Li•Xiangji Ying•Xiangyu Gao•Xiaoqin Li•Xiaotian Zhang•Xiujuan Qu•Xizhi Zhang•Xuefeng Fang•Xuehong Zhao•Yang Fu•Yanqiao Zhang•Ye Chen•Yi Ba•Yifu He•Ying Wang•Yong Gao•Yong Tang•Yongjian Zhou•Yuan Yuan•Yuansong Bai•Yusheng Wang•Zejun Wang•Zengqing Guo•Zhendong Zheng•Zheng Liu•Zhenghua Wang•Zhenyang Liu•Zhifang Yao•Zhixiang Zhuang•Zhongmin Maxwell Wang•Ziyu Li
